StonvexLoading…
StonvexStonvexStonvexCore line items from OPRT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.55M | $19.46M | $14.81M | $9.89M |
Operating Income | $3.56M | $44.08M | $37.51M | $23.27M |
Net Income | $2.35M | $25.25M | $21.84M | $6.88M |
EPS (Diluted) | $0.05 | $0.53 | $0.46 | $0.35 |
Total Assets | $3.17B | $3.26B | $3.19B | $3.20B |
Total Liabilities | $2.77B | $2.87B | $2.80B | $2.83B |
Cash & Equivalents | $130.38M | $105.53M | $104.61M | $96.82M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 45.60M | 44.44M | 44.09M | 44.01M |